ライフサイエンスコーパス: myocardial protection

1 ium (GIK) is a potentially useful adjunct to myocardial protection.

2 ntifying a role for GSNO in angiogenesis and myocardial protection.

3 secondary stroke protection rather than for myocardial protection.

4 tivation is antiapoptotic and contributes to myocardial protection.

5 diomyocytes, which in turn leads to improved myocardial protection.

6 gan (thigh versus arm) would provide further myocardial protection.

7 membrane current, which may be important in myocardial protection.

8 s that may benefit from better postoperative myocardial protection.

9 at-shock protein 70 (HSP 70) plays a role in myocardial protection.

10 ior to ischemia induces preconditioning-like myocardial protection.

11 radykinin B(2) receptor blocker, HOE 140, on myocardial protection.

12 esearch stimulated by interest in endogenous myocardial protection.

13 rane fluxes and metabolic demand and improve myocardial protection.

14 cardioplegia in increasing doses to enhance myocardial protection.

15 d in antithrombotic treatments but little in myocardial protection.

16 cardiopulmonary bypass (CPB), 3) methods of myocardial protection, 4) techniques for aortic occlusio

17 ling a mechanism of metabolic modulation and myocardial protection activated by NO donors.

18 ether these effects could be used to enhance myocardial protection afforded by crystalloid cardiopleg

19 uce hibernation in active animals and afford myocardial protection after ischemia-reperfusion injury.

20 route could be a promising new strategy for myocardial protection against ischemia-reperfusion injur

21 shock protein 72 (HSP72) is known to provide myocardial protection against ischemia-reperfusion injur

22 ls during early myocardial repair, providing myocardial protection against ischemic damage by improvi

23 cule-1 (ICAM-1) has been reported to provide myocardial protection against leukocyte-mediated reperfu

24 However, myocardial protection also can be achieved by partial re

25 ort Akt-MSC-mediated paracrine mechanisms of myocardial protection and functional improvement.

26 tant implications for the design of tailored myocardial protection and operative strategies for diabe

27 for the expression of paracrine factors for myocardial protection and regeneration.

28 ding care to high-risk patients and improved myocardial protection and surgical and anesthetic techni

29 With improved cardiopulmonary bypass, myocardial protection, and surgical techniques the morta

30 yrin-B expression as required for vertebrate myocardial protection as hearts deficient in ankyrin-B s

31 perdynamic contractile response and enhanced myocardial protection, as evidenced by a reduction in my

32 L-Arginine afforded significant myocardial protection, as evidenced by increased develop

33 aladaptive myocardial changes and inadequate myocardial protection at the time of surgery.

34 Strategies to afford myocardial protection both during CABG and in the postop

35 tissue in myocardial injury, contributing to myocardial protection by the mediation of the FGFR1/beta

36 -blood (66:1) cardioplegia provides superior myocardial protection compared with dilute (4:1) cardiop

37 ective chemically-induced cardiac arrest and myocardial protection during global ischaemia.

38 MP and heme, has recently been implicated in myocardial protection during ischemia and reperfusion.

39 KC activity in adult mouse hearts results in myocardial protection during ischemia or reperfusion, he

40 hus, the short-term beneficial role of PC in myocardial protection during MIDCAB may be limited.

41 y bypass surgery and in improving methods of myocardial protection during surgery.

42 , we investigated the potential mechanism of myocardial protection following delta-opioid receptor ac

43 cardioplegia has been the gold standard for myocardial protection for years, but patients undergoing

44 a possible mechanism by which BSJYD provides myocardial protection from hypertension.

45 a cytoprotective gene that confers long-term myocardial protection from ischemia/reperfusion injury.

46 ore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through

47 ed JNK inhibition might also be critical for myocardial protection from ischemia/reperfusion.

48 suggesting the importance of GSHPx-1 gene in myocardial protection from ischemic reperfusion injury.

49 normalization of beta-receptor function and myocardial protection from the effects of catecholamines

50 technically challenging, but new methods of myocardial protection have markedly improved the surgica

51 g with complementary murine studies revealed myocardial protection, improved angiogenesis, inflammato

52 Inadequate myocardial protection in patients undergoing coronary ar

53 To unmask whether CXCR2 mediates direct myocardial protection in the intact heart, wild type and

54 rction angina is associated with significant myocardial protection in the setting of primary percutan

55 Pharmacologic blockade of PI3K abrogated myocardial protection in TLR4(-/-) mice following I/R.

56 by adipocytes is adiponectin, which confers myocardial protection, insulin-sensitization, and antiat

57 Declined myocardial protection is a major feature of diabetic car

58 Local myocardial protection may allow prevention of heart fail

59 The possibility that an innate mechanism of myocardial protection might be inducible in the human he

60 , which could affect the use of aspartate in myocardial protection of hypertrophied hearts.

61 hocardiography, and improved intra-operative myocardial protection techniques have all contributed to

62 ce to presently known principles of surgical myocardial protection using advanced cardioplegic techno

63 Despite optimal current surgical myocardial protection, we found that CA with CBC induced

64 Drugs with delta-opiate activity confer myocardial protection, which is additive to cardioplegia

65 Extent of myocardial protection with cold-crystalloid cardioplegia

66 le gas, is known to provide neurological and myocardial protection without side effects.